Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Sarcoma

Below is an extended Sarcoma patents listing. Click here to return to the Sarcoma main in depth entry.

Patents :

US Patent No.Title
7612201 Pyrazole compounds
7615565 VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
7615611 Human cytokine receptor
7615612 Polypeptide
7615618 Oligonucleotides comprising a non-phosphate backbone linkage
7615622 Methods and compositions for reducing heparan sulfate proteoglycan-mediated clearance of factor VIII
7615626 Methods, agents, and compound screening assays for inducing differentiation of undifferentiatied mammalian cells into osteoblasts
7615628 Imidazopyridine derivatives
7615639 1-pyridyl-benzofuro[3,2-b]pyridin-2(1H)-ones
7615643 Benzimidazole thiophene compounds
7618622 Treatment of Parkinson's disease and related disorders using postpartum derived cells
7615554 Erastin and erastin binding proteins, and uses thereof
7615543 Treatment and prevention of tissue damage
7615529 Methods and compositions for modulating hyperstabilized c-met
7615208 Metal ion-labeled bis-aminoethanethiol-targeting ligand conjugates, compositions, and methods for tissue-specific disease imaging
7615209 Compositions of NDV and methods of use thereof for treatment of cancer
7615210 Treatment of endometriosis
7615213 Antibodies against human interleukin-13 and pharmaceutical compositions thereof
7615221 Compositions and methods for treating cancer
7615223 Selected immunoconjugates for binding to aminophospholipids
7615229 Mutants of the P4 protein of nontypable Haemophilus influenzae with reduced enzymatic activity
7615353 Tivozanib response prediction
7615379 Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer
7615380 Methods for modulating an immune response by modulating KRC activity
7618623 Hybrid adeno-retroviral vector for the transfection of cells
7618626 Combination treatment for non-hematologic malignancies
7618971 Mitotic kinesin inhibitors
7618975 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereof
7618981 Imidazopyridinyl-benzamide anti-cancer agents
7618982 Heteroarylpyrrolopyridinones active as kinase inhibitors
7619006 Conjugated psychotropic drugs and uses thereof
7619057 MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1
7619062 PRO214 polypeptides
7619067 Evolved interferon-alpha polypeptides
7619068 Ovr110 antibody compositions and methods of use
7619071 Antibodies that bind interleukin-17 receptor homologue
7618948 Devices, systems and methods for improving and/or cognitive function through brain delivery of siRNA
7618947 Modulation of HIF-1 beta expression
7618939 Compositions and methods to prevent cancer with cupredoxins
7618629 Manipulation of cytokine levels using CD83 gene products
7618631 Treatment with anti-ErbB2 antibodies and EGFR-targeted drugs
7618632 Method of treating or ameliorating an immune cell associated pathology using GITR ligand antibodies
7618636 Antigenic meningococcal peptides
7618637 Heat shock protein-based vaccines and immunotherapies
7618642 Expression cassettes encoding modified human immunodeficiency virus type 1 subtype C envelope glycoproteins
7618788 Proteome epitope tags and methods of use thereof in protein modification analysis
7618791 Methods of detecting cancer with antibodies to cytokine receptor ZCYTOR19
7618933 Treatment of follicular lymphomas using inhibitors of the LT pathway
7618936 Methods for treating and diagnosing cancer with WNT inhibitory Factor-1 (WIF-1)
7619100 Physiologically active substances

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.